Issue Date: April 7, 2008
Carbogen Amcis Adds High Potency In India
Switzerland-based Carbogen Amcis is adding a high-potency compound manufacturing facility in Bavla, India. The facility will be built on the site of its parent company, Dishman Pharmaceuticals & Chemicals, with technology transferred from a high-potency operation in Bubendorf, Switzerland. According to Carbogen Amcis CEO Mark Griffith, the new facility will allow customers to work with the company from early-stage route development to market supply without volume limitations. The company expects that the facility will be producing highly active cytotoxic and noncytotoxic substances by early 2009.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society